wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q36985597-906D9792-C1A2-40AC-B607-4F5B59A1F347
Q36985597-906D9792-C1A2-40AC-B607-4F5B59A1F347
BestRank
Statement
http://www.wikidata.org/entity/statement/Q36985597-906D9792-C1A2-40AC-B607-4F5B59A1F347
EpCAM overexpression prolongs proliferative capacity of primary human breast epithelial cells and supports hyperplastic growth.
P2860
Q36985597-906D9792-C1A2-40AC-B607-4F5B59A1F347
BestRank
Statement
http://www.wikidata.org/entity/statement/Q36985597-906D9792-C1A2-40AC-B607-4F5B59A1F347
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
7d1b8a7950abe534f06e1ccb332a1d32f2db5e9c
P2860
An open-label, randomized phase II study of adecatumumab, a fully human anti-EpCAM antibody, as monotherapy in patients with metastatic breast cancer.